載入...
Trial of Divalproex for Bipolar Disorder
The safety and effectiveness of divalproex sodium (Depakapote®) in the treatment of 40 children and adolescents, aged 7 to 19 years, with a primary diagnosis of bipolar disorder were evaluated by open-label study (2-8 weeks) at the University of Texas, Galveston; University of Pennsylvania, Philadel...
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Pediatric Neurology Briefs Publishers
2002-10-01
|
| 叢編: | Pediatric Neurology Briefs |
| 主題: | |
| 在線閱讀: | https://www.pediatricneurologybriefs.com/articles/1570 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|